160 related articles for article (PubMed ID: 14987223)
1. Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors.
Slater M; Danieletto S; Gidley-Baird A; Teh LC; Barden JA
Histopathology; 2004 Mar; 44(3):206-15. PubMed ID: 14987223
[TBL] [Abstract][Full Text] [Related]
2. Expression of the apoptotic calcium channel P2X7 in the glandular epithelium.
Slater M; Danieletto S; Barden JA
J Mol Histol; 2005 Mar; 36(3):159-65. PubMed ID: 15900405
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells.
Li X; Qi X; Zhou L; Catera D; Rote NS; Potashkin J; Abdul-Karim FW; Gorodeski GI
Gynecol Oncol; 2007 Jul; 106(1):233-43. PubMed ID: 17482244
[TBL] [Abstract][Full Text] [Related]
4. The P2X7 receptor: a novel biomarker of uterine epithelial cancers.
Li X; Zhou L; Feng YH; Abdul-Karim FW; Gorodeski GI
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1906-13. PubMed ID: 17035398
[TBL] [Abstract][Full Text] [Related]
5. Detection of preneoplasia in histologically normal prostate biopsies.
Slater MD; Delprado WJ; Murphy CR; Barden JA
Prostate Cancer Prostatic Dis; 2001; 4(2):92-96. PubMed ID: 12497044
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
8. Expression of purinergic receptors and modulation of P2X7 function by the inflammatory cytokine IFNgamma in human epithelial cells.
Welter-Stahl L; da Silva CM; Schachter J; Persechini PM; Souza HS; Ojcius DM; Coutinho-Silva R
Biochim Biophys Acta; 2009 May; 1788(5):1176-87. PubMed ID: 19306841
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
11. Molecular identification and localization of P2X receptors in the rat lens.
Suzuki-Kerr H; Vlajkovic S; Donaldson PJ; Lim J
Exp Eye Res; 2008 May; 86(5):844-55. PubMed ID: 18407266
[TBL] [Abstract][Full Text] [Related]
12. High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.
Tidehag V; Hammarsten P; Egevad L; Granfors T; Stattin P; Leanderson T; Wikström P; Josefsson A; Hägglöf C; Bergh A
Eur J Cancer; 2014 Jul; 50(10):1829-1835. PubMed ID: 24726733
[TBL] [Abstract][Full Text] [Related]
13. Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration.
Cesaro A; Brest P; Hofman V; Hébuterne X; Wildman S; Ferrua B; Marchetti S; Doglio A; Vouret-Craviari V; Galland F; Naquet P; Mograbi B; Unwin R; Hofman P
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G32-42. PubMed ID: 20185692
[TBL] [Abstract][Full Text] [Related]
14. Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.
Donnelly-Roberts DL; Jarvis MF
Br J Pharmacol; 2007 Jul; 151(5):571-9. PubMed ID: 17471177
[TBL] [Abstract][Full Text] [Related]
15. Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance.
Josefsson A; Wikström P; Egevad L; Granfors T; Karlberg L; Stattin P; Bergh A
Scand J Urol Nephrol; 2012 Aug; 46(4):247-57. PubMed ID: 22452635
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
17. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer.
Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
BJU Int; 2008 Feb; 101(3):352-9. PubMed ID: 18005209
[TBL] [Abstract][Full Text] [Related]
18. Maitotoxin and P2Z/P2X(7) purinergic receptor stimulation activate a common cytolytic pore.
Schilling WP; Wasylyna T; Dubyak GR; Humphreys BD; Sinkins WG
Am J Physiol; 1999 Oct; 277(4):C766-76. PubMed ID: 10516107
[TBL] [Abstract][Full Text] [Related]
19. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
Epstein JI; Walsh PC; Brendler CB
J Urol; 1994 Nov; 152(5 Pt 2):1721-9. PubMed ID: 7523719
[TBL] [Abstract][Full Text] [Related]
20. CXXC5 expression in prostate cancer: implications for cancer progression.
Benedetti I; De Marzo AM; Geliebter J; Reyes N
Int J Exp Pathol; 2017 Aug; 98(4):234-243. PubMed ID: 29027288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
